English | Español
Patient Daily | Feb 6, 2026

Eli Lilly sees opportunity as Novo Nordisk's oral Wegovy expands obesity drug market
Patient Daily | Feb 6, 2026

Congressman questions transparency of FDA's priority voucher program
Patient Daily | Feb 6, 2026

Eli Lilly expands tirzepatide trials into immunology with combination therapies
Patient Daily | Feb 6, 2026

AbbVie stresses growth beyond immunology as Skyrizi and Rinvoq lead 2025 sales
Patient Daily | Feb 6, 2026

Rare disease drug development sees growth amid regulatory changes
Patient Daily | Feb 6, 2026

Novo Nordisk focuses on Wegovy pill launch amid rising competition and declining sales outlook
Patient Daily | Feb 6, 2026

Penn Medicine workshop uses writing as therapy for cancer patients
Patient Daily | Feb 6, 2026

One quarter of youth on mental health drugs take risky combinations

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Mar 27, 2026

Bayer asks Supreme Court to protect federal regulation from state tort litigation
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’